Exact Mass: 291.15042100000005
Exact Mass Matches: 291.15042100000005
Found 500 metabolites which its exact mass value is equals to given mass value 291.15042100000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyproconazole
CONFIDENCE Parent Substance (Level 1); INTERNAL_ID 2100 CONFIDENCE standard compound; INTERNAL_ID 2568 D016573 - Agrochemicals D010575 - Pesticides
uniconazole
Bunolol
C17H25NO3 (291.18343400000003)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
S-(2-Methylbutanoyl)-dihydrolipoamide
C13H25NO2S2 (291.13266300000004)
S-(2-Methylbutanoyl)-dihydrolipoamide-E is an intermediate in isoleucine degradation. S-(2-Methylbutanoyl)-dihydrolipoamide is normally conjugated to a lysine residue of the methylpropanoyltransferase enzyme (E stands for enzyme). The structure shown here is the free form. Specifically S-(2-Methylbutanoyl)-dihydrolipoamide-E is the 2-methylbutanoyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue (2-methylpropanoyl)transferase. [HMDB] S-(2-Methylbutanoyl)-dihydrolipoamide-E is an intermediate in isoleucine degradation. S-(2-Methylbutanoyl)-dihydrolipoamide is normally conjugated to a lysine residue of the methylpropanoyltransferase enzyme (E stands for enzyme). The structure shown here is the free form. Specifically S-(2-Methylbutanoyl)-dihydrolipoamide-E is the 2-methylbutanoyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue (2-methylpropanoyl)transferase.
S-(3-Methylbutanoyl)-dihydrolipoamide-E
C13H25NO2S2 (291.13266300000004)
S-(3-Methylbutanoyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15975 ). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 3-methyl-hydroxybutyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to 3-methylbutanoyl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase[EC:2.3.1.168]. [HMDB] S-(3-Methylbutanoyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15975 ). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 3-methyl-hydroxybutyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to 3-methylbutanoyl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase[EC:2.3.1.168].
Cyclopentolate
C17H25NO3 (291.18343400000003)
Cyclopentolate is only found in individuals that have used or taken this drug. It is a parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia. [PubChem]By blocking muscarinic receptors, cyclopentolate produces dilatation of the pupil (mydriasis) and prevents the eye from accommodating for near vision (cycloplegia). S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent
Eseridine
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
variotin
C17H25NO3 (291.18343400000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AA - Antibiotics C254 - Anti-Infective Agent > C514 - Antifungal Agent Same as: D01458
Levobunolol
C17H25NO3 (291.18343400000003)
Levobunolol is only found in individuals that have used or taken this drug. It is a nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. [PubChem]Levobunolols mechanism of action in reducing IOP is not clearly defined, but is believed to be due to a reduction of the production of aqueous humor via blockage of endogenous catecholamine-stimulated increases in cyclic adenosine monophosphate (AMP) concentrations within the ciliary processes. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
Benzhydramine HCl
C17H21NO.HCl (291.13898320000004)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D018926 - Anti-Allergic Agents Diphenhydramine hydrochloride is a first-generation histamine H1-receptor antagonist with anti-cholinergic effect. Diphenhydramine hydrochloride can across the ovine blood-brain barrier (BBB)[1][2].
(S)-Edulinine
(S)-Edulinine is found in pomes. (S)-Edulinine is an alkaloid from the bark of Casimiroa edulis (Mexican apple
Norcapsaicin
C17H25NO3 (291.18343400000003)
Isolated from the pungent principle of red pepper (Capsicum annuum). Norcapsaicin is found in many foods, some of which are herbs and spices, italian sweet red pepper, orange bell pepper, and red bell pepper. Norcapsaicin is found in herbs and spices. Norcapsaicin is isolated from the pungent principle of red pepper (Capsicum annuum
Seryltryptophan
Seryltryptophan is a dipeptide composed of serine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Tryptophyl-Serine
Tryptophyl-Serine is a dipeptide composed of tryptophan and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Desethylchloroquine
Desethylchloroquine is the major product of the stereoselective human metabolism of Chloroquine, used for the therapy and prevention of malaria.
2-hydroxy-3-methylbutanedioylcarnitine
C12H21NO7 (291.13179560000003)
2-hydroxy-3-methylbutanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-hydroxy-3-methylbutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-hydroxy-3-methylbutanedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-hydroxy-3-methylbutanedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine
(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is an acylcarnitine. More specifically, it is an (3R)-3,5-dihydroxy-3-methylpentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
4-(Methylsulfanyl)-2-oxobutanoylcarnitine
4-(methylsulfanyl)-2-oxobutanoylcarnitine is an acylcarnitine. More specifically, it is an 4-(methylsulfanyl)-2-oxobutanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-(methylsulfanyl)-2-oxobutanoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 4-(methylsulfanyl)-2-oxobutanoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2R,4S)-1-(Tert-butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid
Befunolol
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
Perlapine
LG 50,051
1-(3,4,5-Trimethoxycinnamoyl)pyrrolidine is a natural product found in Piper lolot and Piper sarmentosum with data available.
syn-3-Isopropyl-6-(4-methoxybenzyl)-4-methylmorpholine-2,5-dione
5H-Dibenzo[a,d]cyclohepten-3-ol,5-[3-(dimethylamino)propylidene]-
4-[[2-[(E)-1-hydroxybut-2-enyl]-5-oxooxolan-3-yl]amino]benzoic acid
4-(3,4-Dimethoxyphenyl)octahydro-2H-quinolizine-2-ol
C17H25NO3 (291.18343400000003)
Di-Me ester,N-tert-butyloxycarbonyl-2-Amino-3-hydroxypentanedioic acid
C12H21NO7 (291.13179560000003)
3-[3-(4-hydroxy-3-methoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
(Z)-1-pyrrolidin-1-yl-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
(7aR)-8c-Aethyl-11c-methyl-(7ar,8ac,11ac,11bt,11cc)-dodecahydro-azepino[3,2,1-hi]furo[3,2-e]indol-2,10-dion|(7aR)-8c-ethyl-11c-methyl-(7ar,8ac,11ac,11bt,11cc)-dodecahydro-azepino[3,2,1-hi]furo[3,2-e]indole-2,10-dione|2-oxo-stenine|2-oxostenine|rel-(7aR,8R,8aS,11S,11aS,11bR,11cR)-8-ethyldodecahydro-11-methylazepino[3,2,1-hi]furo[3,2-e]indole-2,10-dione
C17H25NO3 (291.18343400000003)
(Benzoylamino)acetic acid octyl ester
C17H25NO3 (291.18343400000003)
3-isopropyl-6-(4-methoxybenzyl)-4-methylmorpholine-2,5-dione
(-)-sessilifoliamide C|(9R,9aS)-9-((1S)-1-((2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl)propyl)octahydro-3H-pyrrolo[1,2-a]azepin-3-one|sessilifoliamide C
C17H25NO3 (291.18343400000003)
(5RS)-3-methyl-5-[(1SR,2SR,3aRS,10aSR,10bRS)-1-methyldecahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-yl]furan-2(5H)-one|neostemocochinine
C17H25NO3 (291.18343400000003)
(R)-3-(2-acetoxy-4-phenylbut-3-enoylamino)propionic acid
desulfo-pent-4-enyl GL|desulfoglucobrassicanapin|DS-GBN
1,2-(Methylenedioxy)-7,7-dimethyl-4,5-dihydro-7H-dibenzo[de,g]quinoline
(-)-(2S)-9-hydroxy-2-phenyl-1,5,9-triazacyclotridecan-4-one|Mayfoline
methyl 5-acetamido-1,7-anhydro-3,5-dideoxy-beta-D-glycero-D-galacto-nonulopyranoside
C12H21NO7 (291.13179560000003)
eucatropine
C17H25NO3 (291.18343400000003)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Cyproconazole
D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 86
Prunit
D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 3582
Diphenhydramine Hydrochloride
C17H22ClNO (291.13898320000004)
Diphenhydramine hydrochloride is a first-generation histamine H1-receptor antagonist with anti-cholinergic effect. Diphenhydramine hydrochloride can across the ovine blood-brain barrier (BBB)[1][2].
C15H17NO5_2,6-Piperidinedione, 4-[2-[2-hydroxy-3-(hydroxymethyl)-5-methylphenyl]-2-oxoethyl]
C15H17NO5_Benzoic acid, 4-[[tetrahydro-2-[(2E)-1-hydroxy-2-buten-1-yl]-5-oxo-3-furanyl]amino]
C15H17NO5_Benzoic acid, 4-[[tetrahydro-2-[(1E)-3-hydroxy-1-buten-1-yl]-5-oxo-3-furanyl]amino]
C17H25NO3_Azepino[3,2,1-hi]furo[3,2-e]indole-2,10-dione, 8-ethyldodecahydro-11-methyl-, (7aR,8R,8aS,11S,11aS,11bR,11cR)
C17H25NO3 (291.18343400000003)
4-[[2-[(E)-1-hydroxybut-2-enyl]-5-oxooxolan-3-yl]amino]benzoic acid_major
3H-1,2,4-Triazol-3-one, 5-ethyl-2,4-dihydro-2-(3-hydroxypropyl)-4-(2-phenoxyethyl)-
S-(3-Methylbutanoyl)dihydrolipoyllysine
C13H25NO2S2 (291.13266300000004)
S-(2-Methylbutanoyl)dihydrolipoyllysine
C13H25NO2S2 (291.13266300000004)
(2R,4R)-tert-butyl 2-phenyl-4-vinylthiazolidine-3-carboxylate
C16H21NO2S (291.12929260000004)
TRP-Ser
A dipeptide formed from L-tryptophan and L-serine residues.
Norcapsaicin
C17H25NO3 (291.18343400000003)
Propanoic acid, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-, 1,1-dimethylethyl ester, (2R)-
1-O-benzyl 3-O-methyl 4-oxopiperidine-1,3-dicarboxylate
tert-butyl 4-phenylmethoxypiperidine-1-carboxylate
C17H25NO3 (291.18343400000003)
N-METHYL-GAMMA-(2-METHYLPHENOXY)BENZENEPROPANAMINE HYDROCHLORIDE
C17H22ClNO (291.13898320000004)
Ethyl 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate
C15H22BNO4 (291.16418020000003)
2-(4-CARBOXY-PHENYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
TRANS-1-BOC-2-PHENYL-PYRROLIDINE-3-CARBOXYLIC ACID
methyl 5,5,5-trifluoro-4-(4-methoxyanilino)pentanoate
Tripelennamine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Tripelennamine hydrochloride, an ethylenediamine derivative, is a potent histamine H1-receptor antagonist. Tripelennamine hydrochloride lessens the allergic response of the organism caused by histamine. Tripelennamine hydrochloride can be used for the research of rhinitis, conjunctivitis, and allergic and anaphylactic reactions[1][2][3].
N1-(1-ISOPROPYL-2-METHYLPROPYL)-2-BROMO-3,3-DIMETHYLBUTANAMIDE
TERT-BUTYL 4-(4-(AMINOMETHYL)PHENYL)PIPERAZINE-1-CARBOXYLATE
3-ETHYL-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-INDAZOL-6-AMINE
1-butyl-1-methylpyrrolidin-1-ium,trifluoromethanesulfonate
C10H20F3NO3S (291.11159260000005)
8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-PROPYLAMINE
tert-butyl 4-(4-formylpyridin-2-yl)piperazine-1-carboxylate
TERT-BUTYL 4-(3-(AMINOMETHYL)PHENYL)PIPERAZINE-1-CARBOXYLATE
2-Amino-5-[(3,4,5-Trimethoxyphenyl)Methyl]-1H-Pyrimidin-4-One
Propanoic acid, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-, 1,1-dimethylethyl ester, (2S)-
(2S,6S)-2,6-dibenzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole
tert-butyl 4-(aminomethyl)-4-pyridin-2-ylpiperidine-1-carboxylate
N-(β-Methoxy-m-trifluoromethylphenethyl)carbamic acid ethyl ester
5-chloro-2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
3-DIBENZYLAMINO-2-FLUOROPROPIONIC ACID BENZYL ESTER
N-(2-ETHYLPHENYL)-3-HYDROXY-2-NAPHTHALENECARBOXAMIDE
2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridine-6-carbaldehyde
N-[2-HYDROXYETHYL]BENZAMIDE-4-BORONIC ACID, PINACOL ESTER
C15H22BNO4 (291.16418020000003)
N-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N-(1,3-thiazol-2-yl)ethane-1,2-diamine
C15H21N3OS (291.14052560000005)
tert-butyl 3-(2-hydroxyethyl)-3-phenylpyrrolidine-1-carboxylate
C17H25NO3 (291.18343400000003)
1-(4-chlorobenzyl)-(1H-1，2，4-triazol-yl)-pinacolone
tert-butyl 4-benzyl-4-hydroxypiperidine-1-carboxylate
C17H25NO3 (291.18343400000003)
2-(BOC-AMINO)-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBOXYLIC ACID
TERT-BUTYL4-(2-AMINOPHENYLAMINO)PIPERIDINE-1-CARBOXYLATE
(2,4-DIMETHOXYBENZYLIDENE)CARBAMICACIDCYCLOHEXYLESTER
N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE
C15H22BNO4 (291.16418020000003)
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic Acid Ethyl Ester
9-(4-chloro-3-methoxyphenyl)-3-azaspiro[5.5]undec-9-ene
C17H22ClNO (291.13898320000004)
Ethyl (1R,2S)-2-(Cbz-amino)cyclopentanecarboxylate
4-hydroxy-N-[2-(2-hydroxyethylamino)ethyl]-2-oxo-1H-quinoline-3-carboxamide
4-(2-(2,6-DIMETHYLPIPERIDIN-1-YL)-2-OXOETHOXY)BENZOIC ACID
tert-butyl 4-(hydroxymethyl)-4-phenylpiperidine-1-carboxylate
C17H25NO3 (291.18343400000003)
tert-Butyl 4-[2-(aminomethyl)phenyl]piperazine-1-carboxylate
1H-IMIDAZOLE-4-CARBOXYLIC ACID, 4,5-DIHYDRO-2-[[[(PHENYLMETHOXY)CARBONYL]AMINO]METHYL]-, METHYL ESTER, (S)-
N-Methyl-gamma-(2-methylphenoxy) phenylpropylamine hydrochloride
C17H22ClNO (291.13898320000004)
N-methoxy-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
C15H22BNO4 (291.16418020000003)
Acetamide,N-[(2-hydroxy-1-naphthalenyl)phenylmethyl]-
3-(2-HYDROXY-PHENYLCARBAMOYL)-1,2,2-TRIMETHYL-CYCLOPENTANECARBOXYLIC ACID
(2S,4S)-1-(TERT-BUTOXYCARBONYL)-4-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID
N-BOC-5-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID
[1-(3-AMINO-PHENYL)-PIPERIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER
benzyl 2-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate
4-Methoxy-alpha-methyl-N-(phenylmethyl)benzeneethanamine hydrochloride
C17H22ClNO (291.13898320000004)
4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]morpholine
tert-amyl 2-acetamido-2-deoxy-beta-d-glucopyranoside
but-2-enedioic acid,2-(1H-indol-3-yl)ethylhydrazine
N-Methyl-N-(4-(2-biphenylyloxy)butyl)amine hydrochloride
C17H22ClNO (291.13898320000004)
N-(2-hydroxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
C15H22BNO4 (291.16418020000003)
(R)-(+)-2-Amino-3-methyl-1,1-diphenyl-1-butanol hydrochloride
C17H22ClNO (291.13898320000004)
3-Phenyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester
TERT-BUTYL 4-((PYRIDIN-3-YLMETHYL)AMINO)PIPERIDINE-1-CARBOXYLATE
3-(N,O-Dimethylhydroxylaminocarbonyl)benzeneboronic acid pinacol ester
C15H22BNO4 (291.16418020000003)
Diethylthiambutene
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
tert-butyl 4-(5-formylpyridin-2-yl)piperazine-1-carboxylate
(2R,5S)-1-(TERT-BUTOXYCARBONYL)-5-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID
(2R,4S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenylpyrrolidine-2-carboxylic acid
1-Benzyl 3-methyl 4-oxo-1,3-piperidinedicarboxylate
(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID
(1-(tert-Butoxycarbonyl)-7-methoxy-1H-indol-2-yl)boronic acid
1H-PYRROLO[2,3-B]PYRIDINE, 4-[4-(PHENYLMETHYL)-1-PIPERIDINYL]-
TERT-BUTYL 4-(3-AMINOBENZYL)PIPERAZINE-1-CARBOXYLATE
3-[(2-methylpropan-2-yl)oxycarbonylamino]-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid
4-(4-Aminobenzyl)piperazine-1-carboxylic acid tert-butyl ester
1-(tert-Butoxycarbonyl) 4-phenylpyrrolidine-3-carboxylic acid
ethyl 4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)benzoate
1-(5-methoxy-1,5-dioxopentyl)-4(S)-phenyloxazolidin-2-one
1H-Pyrrole-3-carboxylicacid,4,5-diphenyl-,ethylester(9CI)
1-(tert-Butoxycarbonyl)-4-methoxy-1H-indol-2-ylboronic acid
(S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol hydrochloride
C17H22ClNO (291.13898320000004)
8-((TERT-BUTOXYCARBONYL)AMINO)-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOXYLIC ACID
N-cyclopropyl-3-(1H-indazol-6-yl)-4-methylbenzamide
N-cyclopropyl-3-(1H-indazol-5-yl)-4-methylbenzamide
2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile
1-[(TERT-BUTYL)OXYCARBONYL]-4-PHENYLPYRROLINE-3-CARBOXYLIC ACID
Atomoxetine Hydrochloride
C17H22ClNO (291.13898320000004)
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators Atomoxetine (Tomoxetine) hydrochloride is a selective noradrenaline reuptake inhibitor with Ki values of 5 nM, 77 nM and 1451 nM for norepinephrine (NE), serotonin (5-HT) and dopamine (DA) transporters, respectively. Atomoxetine hydrochloride is a potent Na+ channels (VGSCs) blocker. Atomoxetine hydrochloride can be used for attention-deficit hyperactivity disorder (ADHD) research[1][2][3].
trans-4-[5-(4-ethylcyclohexyl)-2-pyrimidyl]benzonitrile
(2R,4R)-1-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenylpyrrolidine-2-carboxylic acid
(2S,4R)-Boc-4-Phenyl-pyrrolidine-2-carboxylic acid
3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid
methyl (3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinepropanoate
C17H25NO3 (291.18343400000003)
Ethyl (1S,2R)-2-(Cbz-amino)cyclopentanecarboxylate
N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOPROPANAMINE
4-(2,4-DIMETHOXYPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID
2-Tert-Butyl 6-Methyl 3,4-Dihydroisoquinoline-2,6(1H)-Dicarboxylate
2-(4-morpholino)pyrimidine-5-boronic acid pinacol ester
5-tert-Butyl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
(s)-tert-butoxycarbonylamino-indan-1-yl-acetic acid
3-Morpholinone, 4-[4-[(5R)-5-(aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-(R)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
ethyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
C15H22BNO4 (291.16418020000003)
1-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine
(R)-2-(benzofuran-2-yl)-2-((tert-butoxycarbonyl)amino)acetic acid
POLY(3,3,4,4-BIPHENYLTETRACARBOXYLIC DIANHYDRIDE-CO-1,4-PHENYLENEDIAMINE),AMIC ACID
2-(TERT-BUTOXYCARBONYLAMINO)-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBOXYLIC ACID
4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-[1,1-biphenyl]-4-carbonitrile
(s)-4-(4-(5-aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
3-Borono-5-methoxy-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester
1-(2-Adamantyl)-4-nitro-1H-pyrazole-3-carboxylic acid
tert-butyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-sulfanylbutanoate
C13H25NO4S (291.15042100000005)
6-Chloro-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
4-Chloro-1-methylindole-2-boronic acid, pinacol ester
tert-butyl 3-(4-hydroxy-1,3-dioxoisoindol-2-yl)propanoate
3-Nitro-1-(4-octylphenyl)-1-propanone
C17H25NO3 (291.18343400000003)
Benzhydrol, α-(2-(dimethylamino)ethyl)-, hydrochloride
C17H22ClNO (291.13898320000004)
tert-Butyl 3-(trifluoromethyl)-4,5-dihydro-1H-pyrazolo[3,4-c]pyridine-6(7H)-carboxylate
4-(1-((TERT-BUTOXYCARBONYL)AMINO)CYCLOBUTYL)BENZOIC ACID
Benzenamine, N-(3-(dimethylamino)propyl)-4-nitro-2-(trifluoromethyl)-
TERT-BUTYL4-BENZYL-3-HYDROXYPIPERIDINE-1-CARBOXYLATE
C17H25NO3 (291.18343400000003)
1-[(2-methylpropan-2-yl)oxycarbonyl]-2-phenylpyrrolidine-3-carboxylic acid
7-Hydroxy-9-methyl-6-phenyl-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-5-one
(R)-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-BENZYL ESTER 3-ETHYL ESTER
3-(4-CARBOXY-PHENYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Methyl 1-(2-methyl-3-nitrophenyl)-4-oxocyclohexanecarboxylate
4-(4-ACETYL-1-PIPERAZINYL)-3-AMINO-BENZOIC ACID ETHYL ESTER
Danegaptide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
Edonerpic
C16H21NO2S (291.12929260000004)
C26170 - Protective Agent > C1509 - Neuroprotective Agent
N-(5-Cyclopropyl-1H-pyrazol-3-yl)-2-(2-naphthyl)acetamide
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Butinoline
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Clobutinol hydrochloride
D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
3,4-Dimethoxy-alpha-pyrrolidinopentiophenone
C17H25NO3 (291.18343400000003)
2-(5-amino-1H-tetrazol-1-yl)-N-[(E)-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methylidene]acetohydrazide
2-(Anilinomethylidene)-5-phenylcyclohexane-1,3-dione
1-[({[4-(Tert-butyl)cyclohexyliden]amino}oxy)carbonyl]-4-fluorobenzene
8,9,13b,14-tetrahydro-6H-[1,2,4]triazolo[5,1:2,3]pyrimido[4,5:4,5]pyrido[2,1-a]isoquinolin-6-one
7-(4-Methoxyphenyl)-2-(1-pyrrolyl)-[1,2,4]triazolo[1,5-a]pyrimidine
(2S,3S)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
Pecilocin
C17H25NO3 (291.18343400000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AA - Antibiotics C254 - Anti-Infective Agent > C514 - Antifungal Agent
1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine
2,4-Diamino-5-(3,4,5-trimethoxy-benzyl)-pyrimidin-1-ium
(2-Amino-3-phenyl-bicyclo[2.2.1]hept-2-YL)-phenyl-methanone
Befunolol
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
2,6-Piperidinedione, 4-(2-(2-hydroxy-3-(hydroxymethyl)-5-methylphenyl)-2-oxoethyl)-
7-Methyl-oct-6-enoic acid 4-hydroxy-3-methoxy-benzylamide
C17H25NO3 (291.18343400000003)
6-amino-2-[(5-amino-5-carboxypentan-2-yl)amino]-5-hydroxyhexanoic acid
2-hydroxy-3-methylbutanedioylcarnitine
C12H21NO7 (291.13179560000003)
4-Amino-5-(2,5-diamino-5-oxopentanoyl)peroxy-5-oxopentanoic acid
4-hydroxy-3-methoxybenzoic acid [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester
2-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-1H-quinazolin-4-one
5-ethyl-3-[[4-(2-methylpropoxy)phenyl]methylthio]-1H-1,2,4-triazole
C15H21N3OS (291.14052560000005)
1-[(E)-1-(4-Tert-butylphenyl)ethylideneamino]-3-propan-2-ylthiourea
Ala-Asp-Ser
A tripeptide composed of L-alanine, L-aspartic acid, and L-serine joined in sequence by peptide linkages.
Thr-Asp-Gly
A tripeptide composed of L-threonine, L-aspartic acid, and glycine joined by a peptide linkage.
2-fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide
2-fluoro-N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide
2-fluoro-N-[(2R)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide
5-methyl-3-[(4-pentoxyphenyl)methylthio]-1H-1,2,4-triazole
C15H21N3OS (291.14052560000005)
1-(3,4-dimethoxyphenyl)-N-propan-2-yl-1-cyclopentanecarboxamide
C17H25NO3 (291.18343400000003)
2-Hydroxy-2-phenylacetic acid (1,2,6,6-tetramethyl-3-piperidinyl) ester
C17H25NO3 (291.18343400000003)
2-(diphenylmethoxy)-N,N-dimethylethanaminium chloride
C17H22ClNO (291.13898320000004)
(allyl 3-deoxy-7-O-methyl-alpha-D-manno-oct-2-ulopyranosid)onate
(2S)-2-ammonio-6-[(2S)-2-ammonio-4-carboxylato-N-hydroxybutanamido]hexanoate
(3R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyheptanoate
(3S,6R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyheptanoate
2-[4-[(1E,8E)-deca-1,8-dienyl]-2,5-dioxofuran-3-yl]acetate
(2S)-2-[2-[(5S)-5-amino-5-carboxypentyl]hydrazinyl]pentanedioic acid
(2S)-2-amino-6-[[(2S)-2-amino-4-carboxybutanoyl]oxyamino]hexanoic acid
(2S)-2-amino-6-[[(2S)-2-amino-4-carboxybutanoyl]-hydroxyamino]hexanoic acid
5-methyl-2-[(3S)-piperidin-3-yl]-3-pyridin-4-yl-1H-indole
2-Ethoxycarbonyl-4-methoxycarbonyl-1-methyl-5-phenylpyrrolidine (2,4-trans-4,5-cis)
(2S)-N-Carbobenzoxy-2-(4-hydroxy-1-oxobutyl)pyrrolidine
3-[(Diethoxyphosphinyl)methyl]-5-pentyl-2-isoxazoline
C13H26NO4P (291.15993660000004)
N-((1R)-Phenylethyl)-trans-3,4-DI(methoxycarbonyl)pyrrolidine
cyclopentolate
C17H25NO3 (291.18343400000003)
S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent
LEVOBUNOLOL
C17H25NO3 (291.18343400000003)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01ED - Beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
S-(2-Methylbutanoyl)-dihydrolipoamide
C13H25NO2S2 (291.13266300000004)
S-(3-Methylbutanoyl)-dihydrolipoamide-E
C13H25NO2S2 (291.13266300000004)
S(8)-(3-methylbutanoyl)dihydrolipoamide
C13H25NO2S2 (291.13266300000004)
S(8)-(2-methylbutanoyl)dihydrolipoamide
C13H25NO2S2 (291.13266300000004)
methyl 8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-10-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
(2z,7as)-2-[(2e)-1-hydroxydec-2-en-1-ylidene]-tetrahydropyrrolizine-1,3-dione
C17H25NO3 (291.18343400000003)
3-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}prop-2-enenitrile
1-(pyrrolidin-1-yl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
(2r)-2-heptyl-2-hydroxy-6-methoxy-4-methyl-1h-indol-3-one
C17H25NO3 (291.18343400000003)
3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-2-[(1-hydroxyethylidene)amino]propanoic acid
methyl (1s,7s,8r,12r,14s)-8-hydroxy-14-methyl-3-azatetracyclo[9.3.1.0³,¹².0⁷,¹²]pentadec-10-ene-10-carboxylate
C17H25NO3 (291.18343400000003)
6-hydroxy-4-{2-[2-hydroxy-3-(hydroxymethyl)-5-methylphenyl]-2-oxoethyl}-4,5-dihydro-3h-pyridin-2-one
methyl 3-(4-hydroxyphenyl)-2-(3-methyl-2-oxobutanamido)prop-2-enoate
(9r,9as)-9-[(1s)-1-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propyl]-octahydropyrrolo[1,2-a]azepin-3-one
C17H25NO3 (291.18343400000003)